Create Account | Sign In: Author or Forum

Search Symptoms

Category: Family Medicine | Geriatrics | Gastroenterology | Internal Medicine | Nursing | Oncology | Radiology | Surgery | Conference News

Back to Journal Articles

ASCO: Moderate Activity Tied to Longer Survival in Advanced CRC

Last Updated: January 18, 2017.

Just a half hour a day of moderate physical activity could improve survival odds for patients with metastatic colorectal cancer, according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from Jan. 19 to 21 in San Francisco.

WEDNESDAY, Jan. 18, 2017 (HealthDay News) -- Just a half hour a day of moderate physical activity could improve survival odds for patients with metastatic colorectal cancer (CRC), according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from Jan. 19 to 21 in San Francisco.

Study authors who tracked 1,231 CRC patients found a 19 percent decline in risk for early death among those who got 30 minutes or more of moderate exercise daily. Five or more hours of moderate -- but non-vigorous -- activity a week pushed that survival benefit to 25 percent. Walking, cleaning, or gardening counted as moderate exercise, the study authors said.

A half hour of such activity daily also translated into a 16 percent decrease in the progression of disease, the researchers found. The findings held up even after accounting for a range of factors, including patient age, body weight, overall health, other serious disease, or the particular type of cancer treatment underway. The researchers noted that advanced-stage CRC patients only appeared to derive benefit from moderate -- not vigorous -- activity. No similar link was seen with routinely engaging in more strenuous sports or running.

"While exercise is by no means a substitute for chemotherapy, patients can experience a wide range of benefits from as little as 30 minutes of exercise a day," lead author Brendan Guercio, M.D., a resident physician at Brigham and Women's Hospital in Boston, said in a symposium news release.

Press Release
More Information